Sitravatinib CAS: 1123837-84-2
Sitravatinib
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-C-1998 | 50mg | 300.00 | + Add to cart |
|
R-C-1998 | 100mg | 500.00 | + Add to cart |
|
R-C-1998 | 200mg | 790.00 | + Add to cart |
|
|
Product description
Sitravatinib(MGCD516)is an orally bioavailable receptor tyrosine kinase (RTK)inhibitor with IC50s of 1.5nM,2nM,2nM,5nM,6nM,6nM,8nM,0.5nM,2nM,5nM,and 9 nM for Axl,MER,VEGFR3,VEGFR2,VEGFR1,KIT,FLT3,DDR2,DDR1,TRKA,TRKB,respectively. Sitravatinib shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
purity | >95% |
PDI by GPC | <1.5 |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product